Volitionrx (VNRX) Net Cash Flow (2016 - 2025)
Volitionrx filings provide 9 years of Net Cash Flow readings, the most recent being $652971.0 for Q4 2025.
- On a quarterly basis, Net Cash Flow rose 119.55% to $652971.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.7 million, a 84.95% increase, with the full-year FY2025 number at -$2.7 million, up 84.95% from a year prior.
- Net Cash Flow hit $652971.0 in Q4 2025 for Volitionrx, up from -$2.0 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $13.6 million in Q1 2021 to a low of -$9.0 million in Q3 2023.
- Median Net Cash Flow over the past 5 years was -$1.4 million (2023), compared with a mean of -$976706.8.
- The widest YoY moves for Net Cash Flow: up 354.31% in 2021, down 4367.05% in 2021.
- Volitionrx's Net Cash Flow stood at -$2.4 million in 2021, then crashed by 123.58% to -$5.5 million in 2022, then surged by 281.61% to $9.9 million in 2023, then plummeted by 133.7% to -$3.3 million in 2024, then soared by 119.55% to $652971.0 in 2025.
- The last three reported values for Net Cash Flow were $652971.0 (Q4 2025), -$2.0 million (Q3 2025), and -$669448.0 (Q2 2025) per Business Quant data.